ClinicalTrials.govpublic full text
An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
relapsed/refractory warm antibody autoimmune hemolytic anemia, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800344
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.